Lupin Challenges Oscient's Cholesterol Drug Patent
Mumbai, India-based Lupin Ltd. is seeking to gain regulatory approval of a generic version of Oscient Pharmaceuticals Corp.'s drug Antara and is claiming a patent covering the treatment for high cholesterol...To view the full article, register now.
Already a subscriber? Click here to view full article